Pregledni rad

https://doi.org/10.11613/BM.2015.35

Cerebrospinal fluid protein and glucose examinations and tuberculosis: Will laboratory safety regulations force a change of practice?

William P. Tormey ; Department of Chemical Pathology, Beaumont Hospital, Dublin, Ireland
Christopher O’Hagan ; Department of Chemical Pathology, Beaumont Hospital, Dublin, Ireland

Sažetak

Cerebrospinal fluid (CSF) protein and glucose examinations are usually performed in chemical pathology departments on autoanalysers. Tuberculosis (TB) is a group 3 biological agent under Directive 2000/54/EC of the European Parliament but in the biochemistry laboratory, no extra precautions are taken in its analysis in possible TB cases. The issue of laboratory practice and safety in the biochemical analyses of CSF specimens, when tuberculosis infection is in question is addressed in the context of ambiguity in the implementation of current national and international health and safety regulations. Additional protective measures for laboratory staff during the analysis of CSF TB samples should force a change in current laboratory practice and become a regulatory issue under ISO 15189. Annual Mantoux skin test or an interferon-? release assay for TB should be mandatory for relevant staff. This manuscript addresses the issue of biochemistry laboratory practice and safety in the biochemical analyses of CSF specimens when tuberculosis infection is in question in the context of the ambiguity of statutory health and safety regulations.

Ključne riječi

glucose; proteins; cerebrospinal fluid; tuberculosis; safety; accreditation

Hrčak ID:

148679

URI

https://hrcak.srce.hr/148679

Datum izdavanja:

15.10.2015.

Posjeta: 926 *